Literature DB >> 11122861

The dying patient.

J D Cowan1.   

Abstract

Most terminally ill patients experience symptoms that require treatment as death approaches. The most common symptoms are pain (5% to 51%), dyspnea (28%), oral and respiratory secretions (25%), nausea and vomiting (10% to 14%), confusion (10%), myoclonus (12%), and bowel and bladder problems (over 20%). These symptoms can be well controlled in up to 90% of individuals with appropriate communication; emotional, spiritual, and social support; noninvasive clinical evaluation; and therapy focused on symptom palliation. Types of drugs that are important in symptom control include opioids, co-analgesics, anxiolytics, and anticholinergics. To be effective, these medications must be readily available for use and often need to be given by a non-oral route.

Entities:  

Mesh:

Year:  2000        PMID: 11122861     DOI: 10.1007/s11912-000-0026-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  46 in total

1.  Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life.

Authors:  S Grond; D Zech; S A Schug; J Lynch; K A Lehmann
Journal:  J Pain Symptom Manage       Date:  1991-10       Impact factor: 3.612

2.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

3.  Treatment of the dying in the acute care hospital. Advanced dementia and metastatic cancer.

Authors:  J C Ahronheim; R S Morrison; S A Baskin; J Morris; D E Meier
Journal:  Arch Intern Med       Date:  1996-10-14

4.  Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

Authors:  J Lynn; J M Teno; R S Phillips; A W Wu; N Desbiens; J Harrold; M T Claessens; N Wenger; B Kreling; A F Connors
Journal:  Ann Intern Med       Date:  1997-01-15       Impact factor: 25.391

5.  The last 48 hours of life.

Authors:  I Lichter; E Hunt
Journal:  J Palliat Care       Date:  1990       Impact factor: 2.250

6.  A prospective study on the dying process in terminally ill cancer patients.

Authors:  T Morita; T Ichiki; J Tsunoda; S Inoue; S Chihara
Journal:  Am J Hosp Palliat Care       Date:  1998 Jul-Aug       Impact factor: 2.500

7.  The use of chlorpromazine for symptom control in dying cancer patients.

Authors:  B McIver; D Walsh; K Nelson
Journal:  J Pain Symptom Manage       Date:  1994-07       Impact factor: 3.612

8.  A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.

Authors:  W Breitbart; R Marotta; M M Platt; H Weisman; M Derevenco; C Grau; K Corbera; S Raymond; S Lund; P Jacobson
Journal:  Am J Psychiatry       Date:  1996-02       Impact factor: 18.112

Review 9.  Estimating length of survival in end-stage cancer: a review of the literature.

Authors:  N den Daas
Journal:  J Pain Symptom Manage       Date:  1995-10       Impact factor: 3.612

10.  Subcutaneous infusions for control of cancer symptoms.

Authors:  P Storey; H H Hill; R H St Louis; E E Tarver
Journal:  J Pain Symptom Manage       Date:  1990-02       Impact factor: 3.612

View more
  1 in total

1.  Materials to prepare hospice families for dying in the home.

Authors:  Karen A Kehl; Karin T Kirchhoff; Mark P Finster; James F Cleary
Journal:  J Palliat Med       Date:  2008-09       Impact factor: 2.947

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.